Anthony Fauci announced that he plans to step down as Director of the National Institute of Allergy and Infectious Diseases in December 2022.
Anthony Fauci announced on Aug. 22, 2022 that he will be stepping down as the director of the National Institute of Allergy and Infectious Diseases (NIAID) in December 2022. In the statement, he indicated that he would also be stepping down as chief of the NIAID Laboratory of Immunoregulation, as well as the position of Chief Medical Advisor to President Joe Biden.
In the statement, Fauci indicated that he would not be retiring, but instead “[pursuing] the next phase of my career while I still have so much energy and passion for my field.” Fauci did not comment directly on any specific roles, but indicated that he intends to advance public health and mentor future scientific leaders.
“It has been the honor of a lifetime to have led the NIAID, an extraordinary institution, for so many years and through so many scientific and public health challenges,” said Fauci in the statement. “I am very proud of our many accomplishments. I have worked with — and learned from — countless talented and dedicated people in my own laboratory, at NIAID, at NIH and beyond. To them I express my abiding respect and gratitude.”
The full statement can be read on the National Institute of Health’s website here.
Source: National Institute of Health
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.